Unilateral Macular Choroidal Neovascularization; a Rare Manifestation in Chronic Myelogenous Leukemia

PURPOSE: To report a case of chronic myelogenous leukemia (CML) treatment with imatinib mesylate in the remission phase who developed unilateral macular choroidal neovascularization (CNV). METHODS: A 45-year-old male marketer with a 5-year history of CML treated with imatinib mesylate presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pour, Elias Khalili, Bazvand, Fatemeh, Mehrabi Bahar, Mohammad Reza, Abadi, Mahmood Davood, Faghihi, Hooshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265268/
https://www.ncbi.nlm.nih.gov/pubmed/32510022
http://dx.doi.org/10.1016/j.joco.2019.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265268/
https://www.ncbi.nlm.nih.gov/pubmed/32510022
http://dx.doi.org/10.1016/j.joco.2019.09.003

Ejemplares similares